Cargando…
Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells
Paclitaxel is a treatment option for advanced or metastatic bladder cancer after the failure of first-line cisplatin and gemcitabine, although resistance limits its clinical benefits. Mcl-1 is an anti-apoptotic protein that promotes resistance to paclitaxel in different tumors. Obatoclax, a BH3 mime...
Autores principales: | Jiménez-Guerrero, Rocío, Gasca, Jessica, Flores, M. Luz, Pérez-Valderrama, Begoña, Tejera-Parrado, Cristina, Medina, Rafael, Tortolero, María, Romero, Francisco, Japón, Miguel A., Sáez, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316685/ https://www.ncbi.nlm.nih.gov/pubmed/30563080 http://dx.doi.org/10.3390/cancers10120490 |
Ejemplares similares
-
Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer
por: Gasca, Jessica, et al.
Publicado: (2016) -
Wnt/β-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties
por: Jiménez-Guerrero, Rocío, et al.
Publicado: (2021) -
EDIL3 promotes epithelial–mesenchymal transition and paclitaxel resistance through its interaction with integrin α(V)β(3) in cancer cells
por: Gasca, J., et al.
Publicado: (2020) -
Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer
por: Liu, Jing Jing, et al.
Publicado: (2019) -
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
por: Kim, Se Hyun, et al.
Publicado: (2018)